🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To study the effects of acute apomorphine vs. placebo administration on dif...
Status
Unknown
Location
Movement Disorder Program, Foothills Medical Center, Alberta Health Services
Start Date
2022-02-28
Trial ID
NCT04879134
Treatments Being Tested
Study to measure the continued effectiveness of apomorphine after previous ...
Status
Completed
Location
Multiple Locations
Start Date
2001-07
Trial ID
NCT00200525
Treatments Being Tested
The objective of this study was to measure the continued efficacy of apomor...
Status
Completed
Location
Walton Centre for Neurology and Neurosurgery
Start Date
1999-09
Trial ID
NCT00200512
Treatments Being Tested
This study investigates whether the gut hormone glucose-dependent insulinot...
Status
Enrolling By Invitation
Location
Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
Start Date
2026-05-19
Trial ID
NCT07687589
Patients suffering from Parkinson's disease (PD) frequently experienced pai...
Status
Completed
Location
CIC, Purpan Hospital
Start Date
2011-05
Trial ID
NCT01504178
The objective of the present study is to assess dopaminergic reactivity wit...
Status
Completed
Location
CIC Department - University Hospital of Grenoble
Start Date
2011-09
Trial ID
NCT01432821
Treatments Being Tested
This is a placebo-controlled double-blind crossover comparative study of KW...
Status
Completed
Location
Ehime University Hospital
Start Date
2010-01
Trial ID
NCT01058291
Treatments Being Tested
The purpose of this research project is to investigate the safety and toler...
Status
Completed
Location
CMAX Clinical Research Center Pty Limited
Start Date
2025-06-20
Trial ID
NCT06954428
APO303 is a sub-study of patients enrolled in APO401 (the long-term open la...
Status
Completed
Location
Multiple Locations
Start Date
2001-02
Trial ID
NCT00145171
Treatments Being Tested